Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03458871 · ClinicalTrials.gov registry record · NA
Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03458871 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 16 participants.
The verdict
NCT03458871, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Determine the safety, feasibility, compliance, and efficacy of a daily home TTNS protocol in chronic SCI provided by self or caregiver for 4 weeks.
Interventions
- DEVICE 4-week TTNS home-based protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-03-13 |
| Est. Completion | 2019-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03458871
The ClinicalTrials.gov registry entry for NCT03458871 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 4-week TTNS home-based protocol is the first listed.
NCT03458871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03458871 about?
NCT03458871 is a clinical study titled "Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation". Determine the safety, feasibility, compliance, and efficacy of a daily home TTNS protocol in chronic SCI provided by self or caregiver for 4 weeks.
What is the current status of trial NCT03458871?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-03-13. Estimated completion is 2019-02-06.
What interventions are being tested in trial NCT03458871?
The interventions under investigation include: 4-week TTNS home-based protocol (DEVICE).
Who is sponsoring clinical trial NCT03458871?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.